Insulin-like Growth Factor-mediated Muscle Differentiation: Collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin

Medicine & Life Sciences

• Myogenin 89%
• Somatomedins 68%
• Phosphatidylinositol 3-Kinase 65%
• Insulin-Like Growth Factor I 65%
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 57%
• Muscles 38%
• Myoblasts 36%
• Intercellular Signaling Peptides and Proteins 26%
• Insulin-Like Growth Factor Binding Protein 5 24%
• Cell Line 19%
• Muscle Development 18%
• Serum-Free Culture Media 18%
• Skeletal Muscle Fibers 18%
• Regeneration 13%
• Embryonic Structures 13%
• Skeletal Muscle 12%
• Transcription Factors 12%
• Hormones 11%
• Membranes 9%

Chemical Compounds

• Insulin-Like Growth Factor I 100%
• LY294002 88%
• Phosphatidylinositol 77%
• Growth Factor 37%
• Phosphatidylinositol 3 Kinase Inhibitor 27%
• Inhibitory Concentration 20%
• Hormone 16%